119th Congress · introduced in the House · Sep 16, 2025
Health Access Innovation Act of 2025
Official title from Congress.gov
Latest action (Sep 16, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
4 citations.
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…lting the Epidemic of Addiction and Loss Act: Update grant program regulation and guidance to include all FDA opioid reversal agents, not just Naloxone S. 2825/H.R.5417 Health Access Innovation Act 2025: grant program to support faith and community-based organizations in addressing health inequities and chronic disease. S.3199…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$20,000
Spent on own lobbying
…lting the Epidemic of Addiction and Loss Act: Update grant program regulation and guidance to include all FDA opioid reversal agents, not just Naloxone S. 2825/H.R.5417 Health Access Innovation Act 2025: grant program to support faith and community-based organizations in addressing health inequities and chronic disease. S.3199…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 16, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…lting the Epidemic of Addiction and Loss Act: Update grant program regulation and guidance to include all FDA opioid reversal agents, not just Naloxone S. 2825/H.R.5417 Health Access Innovation Act 2025: grant program to support faith and community-based organizations in addressing health inequities and chronic disease. S.3199…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL ALLIANCE ON MENTAL ILLNESS · lobbying firm or registrant: NATIONAL ALLIANCE ON MENTAL ILLNESS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…lting the Epidemic of Addiction and Loss Act: Update grant program regulation and guidance to include all FDA opioid reversal agents, not just Naloxone S. 2825/H.R.5417 Health Access Innovation Act 2025: grant program to support faith and community-based organizations in addressing health inequities and chronic disease. S.3199…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing